AbbVie, a global biopharma, offers 52 consecutive years of dividend increases and a 4% forward dividend yield.
3 Stocks for Decades of Passive Income: AbbVie, a global biopharmaceutical company with 12 blockbuster drugs, offers a strong dividend program with 52 consecutive years of dividend increases and an 4% forward dividend yield. Spinning off from Abbott in 2013, it has increased its dividend payout by over 287%. Two more dividend stocks for long-term passive income are also mentioned, but due to character limit, only AbbVie's highlights are summarized in this response.
May 25, 2024
3 Articles